Soon to start equipping the Royal Navy’s AW159 Wildcat and Marine Nationale’s H160M Guépard shipborne helicopters, the Sea Venom/ANL anti-ship missile is a project developed under the Lancaster House treaty between France and the United Kingdom.
MBDA say that the Sea Venom/ANL anti-ship missile completed its qualification firings trials, with a successful final firing at the French Armament General Directorate (DGA) test site at Ile du Levant on the 17th of November.
The Sea Venom/ANL missile is the first programme to take full advantage of the cross-border centres of excellence on missile technologies launched by the Lancaster House treaty, which celebrated its 10-year anniversary this month.
The final qualification trial tested the missile’s advanced target discrimination within a complex and cluttered naval scenario.
Éric Béranger, MBDA CEO, said:
“I want to congratulate the UK-French teams across both MBDA and our governments for the commitment they have shown in meeting this qualification milestone amid the disruption caused by Covid-19. Together they have proven that through co-operation we can jointly overcome adversity and deliver leading edge military capabilities.”
Previous trials have tested the missiles launch envelope, release envelope and engagement modes, such as its low-altitude sea-skimming flight, lock on after launch, lock on before launch, operator-in-the-loop, and aimpoint refinement.